118 related articles for article (PubMed ID: 32928920)
1. The Inhibitor of Apoptosis Protein Livin Confers Resistance to Fas-Mediated Immune Cytotoxicity in Refractory Lymphoma.
Sugihara E; Hashimoto N; Osuka S; Shimizu T; Ueno S; Okazaki S; Yaguchi T; Kawakami Y; Kosaki K; Sato TA; Okamoto S; Saya H
Cancer Res; 2020 Oct; 80(20):4439-4450. PubMed ID: 32928920
[TBL] [Abstract][Full Text] [Related]
2. Distinct molecular mechanisms of Fas resistance in murine B lymphoma cells.
Mueller CM; Scott DW
J Immunol; 2000 Aug; 165(4):1854-62. PubMed ID: 10925264
[TBL] [Abstract][Full Text] [Related]
3. The antitumor effect of human cord blood-derived dendritic cells modified by the livin α gene in lung cancer cell lines.
Chen H; Jin Y; Chen T; Zhang M; Ma W; Xiong X; Tao X
Oncol Rep; 2013 Feb; 29(2):619-27. PubMed ID: 23152000
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effects of murine bone marrow-derived dendritic cells infected with xenogeneic livin alpha recombinant adenoviral vectors against Lewis lung carcinoma.
Xie J; Xiong L; Tao X; Li X; Su Y; Hou X; Shi H
Lung Cancer; 2010 Jun; 68(3):338-45. PubMed ID: 19671483
[TBL] [Abstract][Full Text] [Related]
5. Manipulation of NK cytotoxicity by the IAP family member Livin.
Nachmias B; Mizrahi S; Elmalech M; Lazar I; Ashhab Y; Gazit R; Markel G; Ben-Yehuda D; Mandelboim O
Eur J Immunol; 2007 Dec; 37(12):3467-76. PubMed ID: 18034418
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, Livin/ML-IAP in lung cancer.
Hariu H; Hirohashi Y; Torigoe T; Asanuma H; Hariu M; Tamura Y; Aketa K; Nabeta C; Nakanishi K; Kamiguchi K; Mano Y; Kitamura H; Kobayashi J; Tsukahara T; Shijubo N; Sato N
Clin Cancer Res; 2005 Feb; 11(3):1000-9. PubMed ID: 15709165
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of livin overcomes radioresistance in nasopharyngeal carcinoma cells.
Ma F; Gu X; Liu JQ; Mo LH; Yang G; Geng XR; Liu ZQ; Liu ZG; Yang PC
PLoS One; 2020; 15(3):e0229272. PubMed ID: 32119704
[TBL] [Abstract][Full Text] [Related]
8. The inhibitor of apoptosis protein Livin (ML-IAP) plays a dual role in tumorigenicity.
Abd-Elrahman I; Hershko K; Neuman T; Nachmias B; Perlman R; Ben-Yehuda D
Cancer Res; 2009 Jul; 69(13):5475-80. PubMed ID: 19549891
[TBL] [Abstract][Full Text] [Related]
9. Immunity to the melanoma inhibitor of apoptosis protein (ML-IAP; livin) in patients with malignant melanoma.
Zhou J; Yuen NK; Zhan Q; Velazquez EF; Murphy GF; Giobbie-Hurder A; Hodi FS
Cancer Immunol Immunother; 2012 May; 61(5):655-65. PubMed ID: 22033581
[TBL] [Abstract][Full Text] [Related]
10. Silencing Livin induces apoptotic and autophagic cell death, increasing chemotherapeutic sensitivity to cisplatin of renal carcinoma cells.
Wang Z; Liu S; Ding K; Ding S; Li C; Lu J; Gao D; Zhang T; Bi D
Tumour Biol; 2016 Nov; 37(11):15133-15143. PubMed ID: 27677286
[TBL] [Abstract][Full Text] [Related]
11. Silencing Livin gene expression to inhibit proliferation and enhance chemosensitivity in tumor cells.
Wang R; Lin F; Wang X; Gao P; Dong K; Zou AM; Cheng SY; Wei SH; Zhang HZ
Cancer Gene Ther; 2008 Jun; 15(6):402-12. PubMed ID: 18340356
[TBL] [Abstract][Full Text] [Related]
12. Livin enhances chemoresistance in head and neck squamous cell carcinoma.
Yoon TM; Kim SA; Lee DH; Lee JK; Park YL; Lee KH; Chung IJ; Joo YE; Lim SC
Oncol Rep; 2017 Jun; 37(6):3667-3673. PubMed ID: 28440463
[TBL] [Abstract][Full Text] [Related]
13. Livin contributes to tumor hypoxia-induced resistance to cytotoxic therapies in glioblastoma multiforme.
Hsieh CH; Lin YJ; Wu CP; Lee HT; Shyu WC; Wang CC
Clin Cancer Res; 2015 Jan; 21(2):460-70. PubMed ID: 25370472
[TBL] [Abstract][Full Text] [Related]
14. Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene.
Wang TS; Ding QQ; Guo RH; Shen H; Sun J; Lu KH; You SH; Ge HM; Shu YQ; Liu P
Biomed Pharmacother; 2010 May; 64(5):333-8. PubMed ID: 19914791
[TBL] [Abstract][Full Text] [Related]
15. Expression and role of the inhibitor of apoptosis protein livin in chemotherapy sensitivity of ovarian carcinoma.
Liu X; Wang A; Gao H; Yuan Z; Jiao Y
Int J Oncol; 2012 Sep; 41(3):1021-8. PubMed ID: 22766624
[TBL] [Abstract][Full Text] [Related]
16. Single-chain antibody-delivered Livin siRNA inhibits human malignant melanoma growth in vitro and in vivo.
Wang H; Yang Y; Wang W; Guan B; Xun M; Zhang H; Wang Z; Zhao Y
Tumour Biol; 2017 May; 39(5):1010428317701645. PubMed ID: 28459204
[TBL] [Abstract][Full Text] [Related]
17. Alteration of TEAD1 expression levels confers apoptotic resistance through the transcriptional up-regulation of Livin.
Landin Malt A; Cagliero J; Legent K; Silber J; Zider A; Flagiello D
PLoS One; 2012; 7(9):e45498. PubMed ID: 23029054
[TBL] [Abstract][Full Text] [Related]
18. Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis.
Mongini PK; Jackson AE; Tolani S; Fattah RJ; Inman JK
J Immunol; 2003 Nov; 171(10):5244-54. PubMed ID: 14607925
[TBL] [Abstract][Full Text] [Related]
19. [Expression of Apoptosis-related Protein Livin and Caspase-3 in Diffuse Large B Cell Lymphoma and Its Clinical Significance].
Jin L; Sui YX; Chen ZZ; Li YH; Wang LP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1664-1669. PubMed ID: 29262894
[TBL] [Abstract][Full Text] [Related]
20. Small-Molecule Natural Product Physachenolide C Potentiates Immunotherapy Efficacy by Targeting BET Proteins.
Tewary P; Brooks AD; Xu YM; Wijeratne EMK; Babyak AL; Back TC; Chari R; Evans CN; Henrich CJ; Meyer TJ; Edmondson EF; de Aquino MTP; Kanagasabai T; Shanker A; Gunatilaka AAL; Sayers TJ
Cancer Res; 2021 Jun; 81(12):3374-3386. PubMed ID: 33837043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
